Nurse study: Aspirin tied to lower cancer risk for patients with enzyme

04/24/2014 | HealthDay News ·

An analysis of data from the Nurses' Health Study and Health Professionals Follow-up Study published in Science Translational Medicine found regular aspirin users with a higher level of a certain genetic enzyme were less likely to develop colon cancer than those who didn't take the drug. The risk of developing colon cancer was 51% lower among regular aspirin users with high levels of the 15-PGDH enzyme in their colon, but only 10% lower among those who had lower levels of the enzyme.

View Full Article in:

HealthDay News ·

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Fremont, CA